Status:
ACTIVE_NOT_RECRUITING
Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?
Lead Sponsor:
University of Utah
Conditions:
Cutibacterium Acnes
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
Prosthetic joint infection is a devastating complication of shoulder arthroplasty. A relatively novel method of preventing PJI has been with the use of a wound protection device. There is minimal inve...
Detailed Description
Prosthetic joint infection (PJI) is a relatively uncommon but devastating complication of shoulder arthroplasty. Published rates of PJI after shoulder arthroplasty range one to ten percent. Since the ...
Eligibility Criteria
Inclusion
- Patients undergoing primary anatomic or reverse shoulder arthroplasty by one of three surgeons will be eligible.
Exclusion
- revision arthroplasty,
- history of ipsilateral shoulder infection,
- patients unable or unwilling to consent,
- prisoners,
- pregnant individuals,
- mentally disabled patients,
- employees of the University of Utah,
- allergy to polyurethane polyester.
Key Trial Info
Start Date :
June 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06513182
Start Date
June 21 2024
End Date
June 1 2029
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Orthopedics
Salt Lake City, Utah, United States, 84108